Pharmafile Logo
Pharmafocus logo
Advanced Search

Manufacturing and Production

Showing 15 posts of 5862 posts found.

chas_taylor

Ceryx Medical announce new chairman Chas Taylor

April 7, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Cardiovascular technology company Ceryx Medical have appointed Chas Taylor as their new chairman. The appointment comes at an interesting time …
Appointment

Valneva’s inactivated COVID-19 vaccine candidate advances to Phase III trial

April 6, 2021 Manufacturing and Production COVID-19, COVID-19 vaccine, Valneva, Valneva vaccine, inactivated vaccine

Specialty vaccine company Valneva’s inactivated COVID-19 jab has shown positive results in a Phase I/II trial, with a seroconversion rate …
News
Janssen sign

Janssen agrees $780 million deal for authorisation of Cidara flu treatment

April 6, 2021 Manufacturing and Production Janssen, cidara, influenza

Janssen has struck a deal worth up to $780 million with Cidara Therapeutics for exclusive worldwide rights to Cidara’s CD388 …
News
Pfizer's Lipitor tablet

Pfizer vaccine 91.3% effective after six months, Phase III study shows

April 6, 2021 Manufacturing and Production BioNTech, COVID-19, COVID-19 vaccine, Pfizer, Pfizer vaccine, pfizer-biontech vaccine

Pfizer and BioNTech’s follow-up study of their COVID-19 vaccine has confirmed the jab’s high efficacy after up to six months, …
News

Alnylam publish successful results from Phase III study of ultra-rare disease

April 6, 2021 Manufacturing and Production

Alnylam Pharmaceuticals, a RNAi therapeutics company, have published successful results from their Phase III study of lumasiran, the first ever …
News

FDA approves first new ADHD drug in a decade

April 6, 2021 Manufacturing and Production ADHD, FDA, paediatric

The FDA have approved the first new drug for the treatment of attention deficit hyperactivity disorder (ADHD) in over a …
News
1558469633615

The Truth Behind the £1.8 Million Drug

March 31, 2021 Manufacturing and Production FDA, NHS, NICE

As NICE approves the most expensive drug ever for use by the NHS, Jack Goddard takes a look at drug …
Feature

J & J to ship up to 400 million vaccines to Africa

March 30, 2021 Manufacturing and Production COVAX, COVID-19, COVID-19 vaccine, Janssen, Johnson & Johnson

Johnson & Johnson has reached an agreement to ship as many as 400 million doses of their COVID-19 vaccine to …
News
Roche building

Roche’s SMA treatment Evrysdi approved by European Commission

March 30, 2021 Manufacturing and Production EMA, European Commission, PTC Therapeutics, Roche, sma, spinal muscular atrophy

The European Commission has granted marketing authorisation to Roche and PTC Therapeutics’ Evrysdi, for the treatment of patients aged 2 …
News

Novartis expands targeted radioligand therapy pipeline

March 30, 2021 Manufacturing and Production

Novartis has announced today that it has obtained exclusive rights to develop therapeutic applications for a library of fibroblast activation …
News
gsk_boronia_australia

GSK to support manufacture of 60m Novavax COVID-19 vaccines

March 30, 2021 Manufacturing and Production COVID-19, GSK, UK, Vaccine

GSK has reached an agreement with Novavax and the UK Government Vaccines Taskforce to support the production of up to …
News
stock-incyte-01-shutter

Incyte receives EC approval for Pemazyre

March 30, 2021 Manufacturing and Production EU

Incyte have received approval from the European Commission (EC) for Pemazyre (pemigatinib), the first new treatment for adults with locally …
News

Zealand’s Zegalogue treatment for hypoglycemia approved by FDA

March 23, 2021 Manufacturing and Production FDA, Zealand Pharma, Zegalogue

The FDA have approved Zealand Pharma’s Zegalogue therapy for the treatment of severe hypoglycemia in patients with diabetes.
News
stock-incyte-01-shutter

Incyte biliary tract cancer treatment approved in Japan

March 23, 2021 Manufacturing and Production EMA, Japan, oncology

The Japanese Ministry of Health, Labour, and Welfare (MHLW) have approved Incyte’s Pemazyre (pemigatinib) for the treatment of patients with …
News
img_4190-e1376666350337-web

Accord Healthcare launches thalidomide for multiple myeloma treatment

March 23, 2021 Manufacturing and Production MHRA, oncology

Accord Healthcare has announced the UK launch of a generic thalidomide, which is used in combination with melphalan and prednisone, …
News
The Gateway to Local Adoption Series

Latest content

Five Facts about the menopause

March 6, 2026

Zello Appoints Kevin Bailey as Group Chief Medical Officer

March 6, 2026

BioDuro establishes joint manufacturing venture with Cenra

March 6, 2026

Symbiosis appoints Joanne Anderson as Chief Commercial Officer

March 6, 2026

Secarna Pharmaceuticals and Curie.Bio expand existing partnership

March 6, 2026